After a period of research and development mAbsolve today announces the formal launch of its Fc silencing technology named STR. Access to the technology platform will be made available through research and commercial licences. mAbsolve scientists and partners have performed extensive in vitro and in vivo analysis of the Fc mutations collecting demonstrating that STR is the first in class solution for Fc silencing.

Posted in